Data / Form D filings / Canopy Biosciences, LLC
Canopy Biosciences, LLC: Form D filings
Canopy Biosciences, LLC, a biotechnology company in Saint Louis, MO, filed 2 Form D notices with the SEC between 2017 and 2018. The latest, on January 3, 2018, reports $2.1 million sold of a $3.4 million offering to 16 investors.
Find out what Canopy Biosciences, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4320 FOREST PARK AVENUE, SUITE 303, Saint Louis, MO, 63108
- Phone
- (314) 615-6325
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1712948
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 3, 2018 | New notice | $3,400,000 | $2,075,000 | $1,325,000 | 16 | Dec 20, 2017 | sec.gov |
| Jul 31, 2017 | New notice | $1,125,000 | $1,125,000 | $0 | 15 | Oct 25, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| CHARLES BOLTEN | Director | |
| CRYSTAL WINKELER | Executive Officer | |
| EDWARD WEINSTEIN | Executive Officer, Director | |
| DAVID SMOLLER | Director | |
| DAVID KINGSLEY | Director |
Every Form D from the week of Jan 1, 2018 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Canopy Biosciences, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.